<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Oral antibiotics for chronic blepharitis - Onghanseng, N - 2021 | Cochrane Library</title> <meta content="Oral antibiotics for chronic blepharitis - Onghanseng, N - 2021 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013697.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Oral antibiotics for chronic blepharitis - Onghanseng, N - 2021 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013697.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD013697.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Oral antibiotics for chronic blepharitis" name="citation_title"/> <meta content="Neil Onghanseng" name="citation_author"/> <meta content="Stanford University" name="citation_author_institution"/> <meta content="onghanseng_neil@yahoo.com" name="citation_author_email"/> <meta content="Sueko M Ng" name="citation_author"/> <meta content="University of Colorado" name="citation_author_institution"/> <meta content="Muhammad Sohail Halim" name="citation_author"/> <meta content="Stanford University" name="citation_author_institution"/> <meta content="Quan Dong Nguyen" name="citation_author"/> <meta content="Stanford University" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="6" name="citation_issue"/> <meta content="10.1002/14651858.CD013697.pub2" name="citation_doi"/> <meta content="2021" name="citation_date"/> <meta content="2021/06/09" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013697.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013697.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013697.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Administration, Oral; Anti-Bacterial Agents [*administration &amp; dosage, adverse effects]; Bias; Blepharitis [*drug therapy]; Chronic Disease; Doxycycline [*administration &amp; dosage, adverse effects]; Drug Administration Schedule; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013697.pub2&amp;doi=10.1002/14651858.CD013697.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013697.pub2&amp;doi=10.1002/14651858.CD013697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013697.pub2&amp;doi=10.1002/14651858.CD013697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013697.pub2&amp;doi=10.1002/14651858.CD013697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013697.pub2&amp;doi=10.1002/14651858.CD013697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013697.pub2&amp;doi=10.1002/14651858.CD013697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013697.pub2&amp;doi=10.1002/14651858.CD013697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013697.pub2&amp;doi=10.1002/14651858.CD013697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013697.pub2&amp;doi=10.1002/14651858.CD013697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013697.pub2&amp;doi=10.1002/14651858.CD013697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013697.pub2&amp;doi=10.1002/14651858.CD013697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013697.pub2&amp;doi=10.1002/14651858.CD013697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013697.pub2&amp;doi=10.1002/14651858.CD013697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013697.pub2&amp;doi=10.1002/14651858.CD013697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013697.pub2&amp;doi=10.1002/14651858.CD013697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013697.pub2&amp;doi=10.1002/14651858.CD013697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013697.pub2&amp;doi=10.1002/14651858.CD013697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013697.pub2&amp;doi=10.1002/14651858.CD013697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013697.pub2&amp;doi=10.1002/14651858.CD013697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013697.pub2&amp;doi=10.1002/14651858.CD013697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013697.pub2&amp;doi=10.1002/14651858.CD013697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013697.pub2&amp;doi=10.1002/14651858.CD013697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013697.pub2&amp;doi=10.1002/14651858.CD013697.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="jxlIh5Me";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD013697\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD013697\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013697\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013697\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","zh_HANT","pt","th","ms","fa","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD013697.pub2",title:"Oral antibiotics for chronic blepharitis",firstPublishedDate:"Jun 9, 2021 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Eyes and Vision Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=jxlIh5Me&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013697.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013697.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD013697.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD013697.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013697.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD013697.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD013697.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD013697.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD013697.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD013697.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>14154 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD013697.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013697.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013697.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013697.pub2/full#CD013697-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013697.pub2/full#CD013697-sec-0069"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013697.pub2/full#CD013697-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013697.pub2/full#CD013697-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013697.pub2/full#CD013697-sec-0016"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013697.pub2/full#CD013697-sec-0017"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013697.pub2/full#CD013697-sec-0042"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013697.pub2/full#CD013697-sec-0063"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013697.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013697.pub2/appendices#CD013697-sec-0074"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013697.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013697.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/supinfo/CD013697StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/supinfo/CD013697StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013697.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013697.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013697.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013697.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013697.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD013697.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2021 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Oral antibiotics for chronic blepharitis</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013697.pub2/information#CD013697-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Neil Onghanseng</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013697.pub2/information#CD013697-cr-0005">Sueko M Ng</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013697.pub2/information#CD013697-cr-0006">Muhammad Sohail Halim</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013697.pub2/information#CD013697-cr-0007">Quan Dong Nguyen</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/information/en#CD013697-sec-0084">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 09 June 2021 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD013697.pub2">https://doi.org/10.1002/14651858.CD013697.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD013697-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013697-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013697-abs-0015">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013697-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013697-abs-0013">Français</a> </li> <li class="section-language"> <a class="" href="full/pt#CD013697-abs-0006">Português</a> </li> <li class="section-language"> <a class="" href="full/th#CD013697-abs-0008">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013697-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD013697-abs-0001" lang="en"> <section id="CD013697-sec-0001"> <h3 class="title" id="CD013697-sec-0001">Background</h3> <p>Posterior blepharitis is common and causes ocular surface and lid damage as well as discomfort. It affects 37% to 47% of all ophthalmology patients; its incidence increasing with age. It is a multifactorial disease associated with multiple other pathologies, such as rosacea, meibomianitis, and infections. Treatment usually focuses on reliefing the symptoms by using artificial tears, lid scrubs, and warm compresses. The condition may be notoriously difficult to manage adequately once it becomes chronic. One such management approach for chronic blepharitis is the use of oral antibiotics for both their antibacterial as well as anti‐inflammatory properties. There are currently no guidelines regarding the use of oral antibiotics, including antibiotic type, dosage, and treatment duration, for the treatment of chronic blepharitis. </p> </section> <section id="CD013697-sec-0002"> <h3 class="title" id="CD013697-sec-0002">Objectives</h3> <p>To assess the benefits and harms of oral antibiotic use for people with chronic blepharitis.</p> </section> <section id="CD013697-sec-0003"> <h3 class="title" id="CD013697-sec-0003">Search methods</h3> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (which contains the Cochrane Eyes and Vision Trials Register) (2020, Issue 8); Ovid MEDLINE; Embase.com; PubMed; Latin American and Caribbean Health Sciences Literature Database (LILACS); ClinicalTrials.gov, and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP). We did not use any date or language restrictions in the electronic search for trials. We last searched the electronic databases on 29 August 2020. </p> </section> <section id="CD013697-sec-0004"> <h3 class="title" id="CD013697-sec-0004">Selection criteria</h3> <p>We included randomized controlled trials (RCTs) comparing oral antibiotics with placebo in adult participants with chronic blepharitis (including staphylococcal, seborrhoeic, or Meibomian Gland Dysfunction (MGD)). </p> </section> <section id="CD013697-sec-0005"> <h3 class="title" id="CD013697-sec-0005">Data collection and analysis</h3> <p>We used standard Cochrane methodology and graded the certainty of the body of evidence for six outcomes using the GRADE classification. </p> </section> <section id="CD013697-sec-0006"> <h3 class="title" id="CD013697-sec-0006">Main results</h3> <p>We included two studies with 220 participants (numbers of eyes unclear). One parallel‐group RCT comparing oral doxycycline (40 mg once a day) with placebo enrolled 70 participants with blepharitis and facial rosacea in the USA. Follow‐up duration was three months. One three‐arm RCT conducted in South Korea investigated the effect of high‐dose (200 mg twice a day) and low‐dose (20 mg twice a day) doxycycline versus placebo after one month of study medication. It enrolled 50 participants with chronic MGD in each study arm (i.e. 150 participants enrolled in total). </p> <p>The two studies did not evaluate the same outcome measurements, which precluded any meta‐analysis. The evidence for the effect of oral antibiotics on subjective improvement in symptoms was very uncertain. One study suggested that there was little to no effect of oral doxycycline on subjective symptoms based on the Ocular Surface Disease Index (OSDI) scores ranging from 0 to 100 (higher score indicates worse condition) (mean difference (MD) 3.55, 95% confidence interval (CI) −4.61 to 11.71; n = 70) and bulbar conjunctival hyperemia ranging from 0 (clear) to 4 (severe) (MD −0.01, 95% CI −0.38 to 0.36; n = 70) at 12 weeks. The three‐arm RCT showed that oral doxycycline may slightly improve number of symptoms (MD −0.56, 95% CI −0.95 to −0.17; n = 93 (high‐dose doxycycline versus placebo); MD −0.48, 95% CI −0.86 to −0.10; n = 93 (low‐dose doxycycline versus placebo)) and proportion of participants with symptom improvement (risk ratio (RR) 6.13, 95% CI 2.61 to 14.42; n = 93 (high‐dose doxycycline versus placebo); RR 6.54, 95% CI 2.79 to 15.30; n = 93 (low‐dose doxycycline versus placebo)) at one month, but the evidence is very uncertain. We judged the certainty of evidence for subjective symptoms as very low. </p> <p>One study evaluated aqueous tear production by Schirmer's test (mm/5 min) (higher score indicates better condition) and tear film stability by measuring tear film break‐up time (TBUT) in seconds (higher score indicates better condition) at one month. We found very low certainty evidence that oral doxycycline may improve these clinical signs. The estimated MD in Schirmer's test score after one month of treatment was 4.09 mm (95% CI 2.38 to 5.80; n = 93) in the high‐dose doxycycline group versus the placebo group and 3.76 mm (95% CI 1.85 to 5.67; n = 93) in the low‐dose doxycycline group versus the placebo group. The estimated MD in TBUT after one month was 1.58 seconds (95% CI 0.57 to 2.59; n = 93) when comparing the high‐dose doxycycline group with the placebo group, and 1.70 seconds (95% CI 0.96 to 2.44; n = 93) when comparing the low‐dose doxycycline group with the placebo group. Although there was a noted improvement in these scores, their clinical importance remains uncertain. </p> <p>One study suggested that oral doxycycline may increase the incidence of serious side effects: 18 (39%) participants in the high‐dose doxycycline group, 8 (17%) in the low‐dose doxycycline group, and 3 (6%) out of 47 participants in the placebo group experienced serious side effects (RR 6.13, 95% CI 1.94 to 19.41; n = 93 (high‐dose doxycycline versus placebo); RR 2.72, 95% CI 0.77 to 9.64; n = 93 (low‐dose doxycycline versus placebo)). Additionally, one study reported that one case of migraine headache and five cases of headache were observed in the oral doxycycline group, and one case of non‐Hodgkin's lymphoma was observed in the placebo group. We judged the certainty of evidence for adverse events as very low. </p> </section> <section id="CD013697-sec-0007"> <h3 class="title" id="CD013697-sec-0007">Authors' conclusions</h3> <p>There was insufficient evidence to draw any meaningful conclusions on the use of oral antibiotics for chronic blepharitis. Very low certainty evidence suggests that oral antibiotics may improve clinical signs, but may cause more adverse events. The evidence for the effect of oral antibiotics on subjective symptoms is very uncertain. Further trials are needed to provide high quality evidence on the use of oral antibiotics in the treatment of chronic blepharitis. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD013697-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013697-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013697-abs-0016">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013697-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013697-abs-0014">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD013697-abs-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pt#CD013697-abs-0007">Português</a> </li> <li class="section-language"> <a class="" href="full/th#CD013697-abs-0009">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013697-abs-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD013697-abs-0005">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD013697-abs-0002" lang="en"> <h3>Treating long‐lasting blepharitis (swollen and itchy eyelids): how well do antibiotics (medicines that kill bacteria) work when taken by mouth (orally)? </h3> <p><b>Key messages</b><br/>· We did not find enough evidence to show how well antibiotics taken by mouth can treat long‐lasting blepharitis. </p> <p>· One antibiotic tested may improve some clinical aspects (symptoms and course of the disease), but we are uncertain about its benefit in this respect, and it may also cause a higher number of unwanted effects. </p> <p>· More studies are needed to find out how well antibiotics taken by mouth can treat long‐lasting blepharitis. </p> <p><b>What is blepharitis?</b><br/>Blepharitis is a common condition affecting the eyes. It causes swelling and redness on the edges of the eyelids, making them feel sore, and an itching or a gritty feeling in the eyes. The most common causes of blepharitis are infection by a type of bacteria that lives on the surface of the eye, or skin conditions such as dermatitis. </p> <p><b>How is blepharitis treated?</b><br/>Blepharitis is usually treated by regularly cleaning the eyelids, or using a cream or eye drops containing an antibiotic (a type of medicine that kills bacteria). If these do not work, then taking antibiotics by mouth (orally) is often tried. However, there are no guidelines about which type of antibiotic to give, what dose to use, or how long treatment should last. </p> <p><b>What did we want to find out?</b><br/>We wanted to find out how well antibiotics given by mouth can treat long‐lasting blepharitis. </p> <p><b>What did we do?</b><br/>We searched for studies that tested antibiotics given by mouth to treat long‐lasting blepharitis. </p> <p><b>What did we find?</b><br/>We found 2 studies in 220 adults with long‐lasting blepharitis. One study took place in the USA and lasted for three months; it tested the antibiotic doxycycline compared to placebo treatment (a 'dummy' treatment that does not contain any medicine but looks identical to the medicine being tested). The other study took place in South Korea and tested the effects of high or low doses of doxycycline compared to placebo treatment. </p> <p>One study was funded by a pharmaceutical company; the other study did not report a source of funding. The studies measured results of treatment in different ways, so it was not possible to combine the studies' results to analyse them together. </p> <p><b>What are the main results of our review?</b><br/>We are uncertain about the effects of doxycycline on symptoms such as itching, burning, and watery eyes, as evaluated by people taking part in the studies. </p> <p>One study measured changes in how much an affected eye watered (produced tears) before and after one month of treatment. High‐ and low‐dose doxycycline may improve the eye's ability to produce tears (evidence from 1 study with 93 people in each dose group). </p> <p>One study evaluated dryness of the eye by measuring the time it took for a dry spot to appear on the surface of the eye after blinking (the 'tear film break‐up time'). Taking doxycycline (high‐ and low‐dose) for one month may improve problems with dryness (evidence from 1 study with 93 people in each dose group). </p> <p>Taking doxycycline for one month may cause more unwanted effects than taking a placebo (evidence from 1 study in 139 people). The number of unwanted effects reported was higher in the high‐dose doxycycline group. </p> <p>No studies measured:</p> <p>· how many bacteria were present in the eye before or after treatment;</p> <p>· people's well‐being (quality of life); or</p> <p>· the costs and benefits of the treatments tested.</p> <p><b>What are the limitations of the evidence?</b><br/>We have very low confidence in the evidence because of limitations in the ways the studies were conducted, and because the results of the studies varied widely and were inconsistent. One study was funded by a pharmaceutical company, which could have affected the way the study was designed, conducted, and reported. Further research is likely to change and increase our confidence in the results. </p> <p><b>How up‐to‐date is the evidence?</b><br/>The evidence is current up to 29 August 2020. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD013697-sec-0069" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD013697-sec-0069"></div> <h3 class="title" id="CD013697-sec-0070">Implications for practice</h3> <section id="CD013697-sec-0070"> <p>The exact indications, dose requirement, and length of treatment for the use of oral antibiotics in the management of chronic blepharitis remains unclear. Based on existing clinical trial evidence, there may be some benefit but the evidence is very uncertain to permit a meaningful suggestion for this treatment approach. Safety and patient tolerability of using long‐term oral antibiotics, particularly tetracyclines, appears to be within acceptable margins, with encountered side effects being generally mild and consisting of general antibiotic‐associated side effects such as headache, nausea, and gastrointestinal distress. It is also important to note that systemic etiologies, such as facial rosacea, may necessitate the use of systemic antibiotics as part of their treatment. Other infectious etiologies, such as demodicosis, will carry their own etiology‐specific treatments as well. With respect to dose of oral antibiotics, the evidence does not clearly support a benefit to using high‐ versus low‐dose oral antibiotics for improvement in ophthalmologic signs and symptoms; on the other hand, the use of high‐dose antibiotic may result in a higher adverse effect profile. Consequently, monitoring patients remains important in order to screen for and respond early to any potential adverse event during treatment. </p> </section> <h3 class="title" id="CD013697-sec-0071">Implications for research</h3> <section id="CD013697-sec-0071"> <p>Further research is required to provide high quality evidence on the use of oral antibiotics for the treatment of chronic blepharitis. Specifically, future studies would benefit from larger population sizes, standardized drug dosages, and the use of other antibiotics from different antibiotic classes, including macrolides (e.g. azithromycin, erythromycin, or clarithromycin), since tetracyclines are contraindicated in certain conditions such as pregnancy, to shed light on the overall efficacy of oral antibiotics for the treatment of chronic blepharitis. Scrutiny of etiology of chronic blepharitis is also crucial in future research, as different causes may respond differently to oral antibiotics due to the multifactorial nature of the disease. Some etiologies such as facial rosacea show good systemic response to antibiotic therapy, while others such as demodicosis require additional therapy to terminate lid infestations. </p> <p>The development of a standardized method to measure ocular signs (e.g. tear film break‐up time and Schirmer's test) and the use of valid questionnaires to document subjective improvement in symptoms (e.g. eye discomfort) are also necessary to synthesize evidence across studies. Longitudinal assessment of intervention effects beyond one to three months may also provide valuable insights into treatment effects in the longer term. Furthermore, any measurement of clinical signs that inherently carry a high degree of subjectivity, such as eye redness, requires the development of rigidly worded descriptors, ideally with standardized reference photos. Lastly, future studies should be rigorously designed including sample sizes with appropriate calculation based on the estimated effects. Investigators should report adequate information by following the CONSORT statement for randomized controlled trials. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD013697-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD013697-sec-0008"></div> <div class="table" id="CD013697-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Oral antibiotics compared with placebo for chronic blepharitis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Oral antibiotics compared with placebo for chronic blepharitis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adult participants with chronic blepharitis </p> <p><b>Settings:</b> tertiary care, university hospital, or private practice </p> <p><b>Intervention:</b> oral antibiotics </p> <p><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="table-header separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Placebo</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Oral antibiotics</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="8" valign="top"> <p><b>Subjective improvement in symptoms at 1 month and 3 months</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>OSDI, ranging from 0 to 100 (higher score indicates worse condition)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>70</p> <p>(1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="8" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low<sup>1,2,3</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean  OSDI score decreased 8.70 at 3 months.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean decrease in OSDI score at 3 months was on average <b>3.55 smaller</b> (95% CI −4.61 to 11.71). </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Bulbar conjunctival hyperemia, ranging from 0 (clear) to 4 (severe)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>70</p> <p>(1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean  bulbar conjunctival hyperemia decreased 0.60 at 3 months.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean decrease in bulbar conjunctival hyperemia at 3 months was on average <b>0.01 greater</b> (95% CI −0.38 to 0.36). </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Number of symptoms (higher score indicates worse condition)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>93 each analysis</p> <p>(1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of symptoms at 1 month was 2.01.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of symptoms at 1 month was on average <b>0.56 fewer</b> (95% CI −0.95 to −0.17) in the high‐dose group and <b>0.48 fewer</b> (95% CI −0.86 to −0.10) in the low‐dose group. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Proportion of participants with improvement</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 6.13</b> (95% CI 2.61 to 14.42) high dose vs placebo, <b>RR 6.54</b> (95% CI 2.79 to 15.30) low dose vs placebo </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>93 each analysis</p> <p>(1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>106 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>652 per 1000 (95% CI 507 to 773) in the high‐dose group and 696 per 1000 (95% CI 552 to 809) in the low‐dose group </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Measurements of eradication or decrease in numbers of colonies of positive cultures of bacteria</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No data were available for this outcome.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Clinical signs—Schirmer test scores at 1 month (mm/5 min)</b>  </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Range: 0 to 20, higher scores indicate better conditions<br/>  </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>93 each analysis</p> <p>(1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low<sup>1,2</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean Schirmer test scores in the placebo group were 15.89.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean Schirmer test scores in the intervention group were on average <b>4.09 greater</b> (95% CI 2.38 to 5.80) in the high‐dose group and <b>3.76 greater</b> (95% CI 1.85 to 5.67) in the low‐dose group. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Clinical signs—TBUT at 1 month (seconds)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Range: 0 to 10, longer is better<br/>  </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>93 each analysis</p> <p>(1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low<sup>1,2</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean TBUT in the placebo group was 7.84</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean TBUT in the intervention group was on average <b>1.58 greater</b> (95% CI 0.57 to 2.59) in the high‐dose group and <b>1.70 greater</b> (95% CI 0.96 to 2.44) in the low‐dose group. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse events</b> </p> <p><b>at 1 month</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Cardinal side effects</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 6.13</b> (95% CI 1.94 to 19.41) high dose vs placebo, <b>RR 2.72</b> (95% CI 0.77 to 9.64) low dose vs placebo </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>93 each analysis</p> <p>(1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low<sup>1,2</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Additional 1 study reported 1 case of migraine headache and 5 cases of headaches in the oral doxycycline group, and 1 case of non‐Hodgkin's lymphoma in the placebo group (<a href="./references#CD013697-bbs2-0001" title="NCT00560703. Treatment of patients with blepharitis and facial rosacea [Efficacy and safety of COL-101 for the treatment of blepharitis in patients with facial rosacea]. clinicaltrials.gov/ct2/show/NCT00560703 (first received 20 November 2007). ">NCT00560703</a>). </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>64 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>391 per 1000 (high‐dose group)</p> <p>174 per 1000 (low‐dose group)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life measures</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No data were available for this outcome.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Economic costs and benefits of different interventions</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No data were available for this outcome.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The <b>assumed risk</b>  is based on the estimate in the control group. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>OSDI:</b> Ocular Surface Disease Index; <b>RR:</b> risk ratio; <b>TBUT:</b> tear film break‐up time </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> </p> <p><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded one level for study limitations due to high risk of attrition or reporting bias among the included studies.<br/><sup>2</sup>Downgraded one or two levels for imprecision due to wide confidence intervals.<br/><sup>3</sup>Downgraded one level for inconsistency of results. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD013697-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD013697-sec-0009"></div> <section id="CD013697-sec-0010"> <h3 class="title" id="CD013697-sec-0010">Description of the condition</h3> <p>Blepharitis, defined as inflammation of the eyelids, is one of the most common ocular conditions and affects both children and adults (<a href="./references#CD013697-bbs2-0052" title="LempMA , NicholsKK . Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment. Ocular Surface2009;7(Suppl 2):S1-14.">Lemp 2009</a>; <a href="./references#CD013697-bbs2-0069" title="ViswalinghamM , RauzS , MorletN , DartJK . Blepharokeratoconjunctivitis in children: diagnosis and treatment. British Journal of Ophthalmology2005;89(4):400-3.">Viswalingham 2005</a>). It can be classified either by anatomic area or by chronicity. Anterior blepharitis is defined as disease affecting the eyelid skin up to the lash base and follicles, while posterior blepharitis affects the meibomian glands (<a href="./references#CD013697-bbs2-0033" title="American Academy of Ophthalmology Preferred Practice Pattern Cornea/External Disease Committee, Hoskins Center for Quality Eye Care. Blepharitis PPP-2018. www.aao.org/preferred-practice-pattern/blepharitis-ppp-2018 (accessed 4 June 2020).">AAO 2018</a>). Acute blepharitis, which responds relatively well to treatment, may be bacterial, viral, or parasitic in etiology (<a href="./references#CD013697-bbs2-0041" title="EliasonJA , KrachmerJH , MannisMJ , HollandEJ . Blepharitis: overview and classification. In: KrachmerJH , MannisMJ , HollandEJ , editors(s). Cornea. 2nd edition. Philadelphia: Elsevier Mosby, 2005:481-4.">Eliason 2005</a>), and is beyond the scope of this review. The more common form is chronic blepharitis, the clinical course of which tends to be indolent and recurring, distinguishing itself from the acute form. Chronic blepharitis can be further subdivided into three categories: staphylococcal, seborrhoeic, and meibomian gland dysfunction (MGD). However, the disease may also present as any combination of these three categories (<a href="./references#CD013697-bbs2-0033" title="American Academy of Ophthalmology Preferred Practice Pattern Cornea/External Disease Committee, Hoskins Center for Quality Eye Care. Blepharitis PPP-2018. www.aao.org/preferred-practice-pattern/blepharitis-ppp-2018 (accessed 4 June 2020).">AAO 2018</a>). This review focuses on chronic blepharitis, and does not include blepharokeratoconjunctivitis, which has been evaluated by other Cochrane Reviews (<a href="./references#CD013697-bbs2-0060" title="O'GallagherM , BantekaM , BunceC , LarkinF , TuftS , Dahlmann-NoorA . Systemic treatment for blepharokeratoconjunctivitis in children. Cochrane Database of Systematic Reviews2016, Issue 5. Art. No: CD011750. [DOI: 10.1002/14651858.CD011750.pub2]">O'Gallagher 2016</a>; <a href="./references#CD013697-bbs2-0061" title="O'GallagherM , BunceC , HingoraniM , LarkinF , TuftS , Dahlmann-NoorA . Topical treatments for blepharokeratoconjunctivitis in children. Cochrane Database of Systematic Reviews2017, Issue 2. Art. No: CD011965. [DOI: 10.1002/14651858.CD011965.pub2]">O'Gallagher 2017</a>). </p> <p>The two most common etiologies of anterior blepharitis are staphylococcal and seborrhoeic blepharitis. Staphylococcal blepharitis is believed to be associated with staphylococcal bacteria on the ocular surface, and is characterized by irritative redness of the lid margin that may have accompanying skin changes such as crusting or scaling. Toxins produced by certain strains of <i>Staphylococcus aureus</i> or <i>Staphylococcus epidermidis</i> may be a cause of irritation (<a href="./references#CD013697-bbs2-0067" title="ValentonMJ , OkumotoM . Toxin-producing strains of Staphylococcus epidermidis (albus). Isolates from patients with staphylococcic blepharoconjunctivitis. Archives of Ophthalmology1973;89(3):186-9.">Valenton 1973</a>). Seborrheic blepharitis is characterized by less inflammation than staphylococcal blepharitis, but with more oily or greasy scaling. Some people with seborrhoeic blepharitis also exhibit characteristics of MGD. </p> <p>Posterior blepharitis has various causes, such as MGD, infectious or allergic conjunctivitis, and systemic conditions such as acne rosacea (<a href="./references#CD013697-bbs2-0059" title="NelsonJD , ShimazakiJ , Benitez-del-CastilloJM , CraigJP , McCulleyJP , DenS , et al. The International Workshop on Meibomian Gland Dysfunction: Report of the Definition and Classification Subcommittee. Investigative Ophthalmology &amp; Visual Science2011;52(4):1930–7.">Nelson 2011</a>). MGD is defined by the International Workshop on Meibomian Gland Dysfunction as "a chronic, diffuse abnormality of the meibomian glands, commonly characterized by terminal duct obstruction and/or qualitative/quantitative changes in the glandular secretion that may result in alteration of the tear film, symptoms of eye irritation, clinically apparent inflammation, and ocular surface disease" (<a href="./references#CD013697-bbs2-0042" title="GeerlingG , TauberJ , BaudouinC , GotoE , MatsumotoY , O'BrienT , et al. The International Workshop on Meibomian Gland Dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. Investigative Ophthalmology &amp; Visual Science2011;52(4):2050-64.">Geerling 2011</a>). Quantitative or qualitative deficiencies in meibum may be responsible for the symptoms experienced in MGD blepharitis. Hyperkeratinization of the meibomian gland epithelium (thickening of the lining of the glands) may lead to obstruction and a decrease in the quantity of meibomian gland secretions (<a href="./references#CD013697-bbs2-0048" title="JesterJV , NicolaidesN , Kiss-PalvolgyiI , SmithRE . Meibomian gland dysfunction. II. The role of keratinization in a rabbit model of MGD. Investigative Ophthalmology &amp; Visual Science1989;30(5):936-45.">Jester 1989a</a>; <a href="./references#CD013697-bbs2-0049" title="JesterJV , NicolaidesN , SmithRE . Meibomian gland dysfunction. I. Keratin protein expression in normal human and rabbit meibomian glands. Investigative Ophthalmology &amp; Visual Science1989;30(5):927-35.">Jester 1989b</a>). </p> <p>Demodex mites are also considered to be a causative factor for blepharitis (<a href="./references#CD013697-bbs2-0037" title="CzepitaD , Kuźna-GrygielW , CzepitaM , GrobelnyA . Demodex folliculorum and Demodex brevis as a cause of chronic marginal blepharitis. Annales Academiae Medicae Stetinensis2007;53(1):63-7.">Czepita 2007</a>). The mites, which infest the eyelid margin around the lash follicles and sebaceous glands, may have a role in both anterior and posterior blepharitis. Overgrowth of the mite population may be responsible for the ocular discomfort of blepharitis, as larger populations of the mites per cilia have been found to correlate with greater levels of ocular discomfort (<a href="./references#CD013697-bbs2-0051" title="LeeSH , ChunYS , KimJH , KimES , KimJC . The relationship between Demodex and ocular discomfort. Investigative Ophthalmology &amp; Visual Science2010;51(6):2906-11.">Lee 2010</a>). </p> <p>Important comorbid conditions that predispose towards the development of blepharitis are acne rosacea, giant papillary conjunctivitis, and the use of the acne drug isotretinoin. Blepharitis may also result as a sequela of infections, various immunologic conditions, dermatologic conditions, toxic conditions, malignancy, and trauma (<a href="./references#CD013697-bbs2-0033" title="American Academy of Ophthalmology Preferred Practice Pattern Cornea/External Disease Committee, Hoskins Center for Quality Eye Care. Blepharitis PPP-2018. www.aao.org/preferred-practice-pattern/blepharitis-ppp-2018 (accessed 4 June 2020).">AAO 2018</a>). These factors are numerous and beyond the scope of this review. </p> <section id="CD013697-sec-0011"> <h4 class="title">Epidemiology</h4> <p>Although not sight‐threatening, chronic blepharitis is one of the most common ocular disorders encountered by ophthalmologists (<a href="./references#CD013697-bbs2-0058" title="McCulleyJP , ShineWE . Changing concepts in the diagnosis and management of blepharitis. Cornea2000;19(5):650-8.">McCulley 2000</a>). In a survey of US ophthalmologists and optometrists, 37% to 47% of people seen by those surveyed had signs of blepharitis (<a href="./references#CD013697-bbs2-0052" title="LempMA , NicholsKK . Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment. Ocular Surface2009;7(Suppl 2):S1-14.">Lemp 2009</a>). A 10‐year population‐based study of over one million people in South Korea found the incidence of clinically diagnosed blepharitis to be 1.1% per 100 person‐years, with an overall prevalence of 8.1%. The incidence and prevalence were higher in females and in those over 40 years old (<a href="./references#CD013697-bbs2-0064" title="RimTH , KangMJ , SeoKY , KimSS . Ten-year incidence and prevalence of clinically diagnosed blepharitis in South Korea: a nationwide population-based cohort study. Clinical and Experimental Ophthalmology2017;45(5):448-54.">Rim 2017</a>). However, there have been too few epidemiologic studies to date to permit estimation of the true prevalence of blepharitis worldwide. </p> <p>It has been postulated that staphylococcal blepharitis occurs more frequently in warmer climates (<a href="./references#CD013697-bbs2-0036" title="BowmanRW , DoughertyJM , McCulleyJP . Chronic blepharitis and dry eyes. International Ophthalmology Clinics1987;27(1):27-35.">Bowman 1987</a>). In a case‐control study conducted in the San Francisco Bay Area and Texas, staphylococcal blepharitis occurred more commonly in women, and had an average age of onset of 42 years (<a href="./references#CD013697-bbs2-0055" title="McCulleyJP , DoughertyJM , DeneauDG . Classification of chronic blepharitis. Ophthalmology1982;89(10):1173-80.">McCulley 1982</a>; <a href="./references#CD013697-bbs2-0057" title="McCulleyJP , DoughertyJM . Blepharitis associated with acne rosacea and seborrheic dermatitis. International Ophthalmology Clinics1985;25(1):159-72.">McCulley 1985</a>). Approximately 25% to 50% of cases were associated with keratoconjunctivitis sicca (KCS), a class of dry eye syndrome (<a href="./references#CD013697-bbs2-0055" title="McCulleyJP , DoughertyJM , DeneauDG . Classification of chronic blepharitis. Ophthalmology1982;89(10):1173-80.">McCulley 1982</a>; <a href="./references#CD013697-bbs2-0057" title="McCulleyJP , DoughertyJM . Blepharitis associated with acne rosacea and seborrheic dermatitis. International Ophthalmology Clinics1985;25(1):159-72.">McCulley 1985</a>). </p> <p>In the same study, the mean age of participants with seborrhoeic blepharitis was 50 years (<a href="./references#CD013697-bbs2-0057" title="McCulleyJP , DoughertyJM . Blepharitis associated with acne rosacea and seborrheic dermatitis. International Ophthalmology Clinics1985;25(1):159-72.">McCulley 1985</a>). There was no difference in prevalence between men and women for this type of blepharitis. Ninety‐five per cent of participants with seborrhoeic blepharitis also had seborrhoeic dermatitis that presents with symptoms of flaking and greasy skin on the scalp, retroauricular area, glabella, and nasolabial folds (<a href="./references#CD013697-bbs2-0055" title="McCulleyJP , DoughertyJM , DeneauDG . Classification of chronic blepharitis. Ophthalmology1982;89(10):1173-80.">McCulley 1982</a>); approximately one‐third of these participants had KCS (<a href="./references#CD013697-bbs2-0056" title="McCulleyJP . Blepharoconjunctivitis. International Ophthalmology Clinics1984;24(2):65-77.">McCulley 1984</a>). </p> <p>The incidence of MGD increases with age (<a href="./references#CD013697-bbs2-0040" title="DriverPJ , LempMA , KrachmerJH , MannisMJ , HollandEJ , KrachmerJH , et al. Seborrhea and meibomian gland dysfunction. In: KrachmerJH , MannisMJ , HollandEJ , editors(s). Cornea. 2nd edition. Philadelphia: Elsevier Mosby, 2005:485-91.">Driver 2005</a>). The average age in the <a href="./references#CD013697-bbs2-0055" title="McCulleyJP , DoughertyJM , DeneauDG . Classification of chronic blepharitis. Ophthalmology1982;89(10):1173-80.">McCulley 1982</a> group of people with MGD blepharitis was 50 years old, and prevalence was equal between men and women (<a href="./references#CD013697-bbs2-0056" title="McCulleyJP . Blepharoconjunctivitis. International Ophthalmology Clinics1984;24(2):65-77.">McCulley 1984</a>). MGD may be more common in cooler climates (<a href="./references#CD013697-bbs2-0036" title="BowmanRW , DoughertyJM , McCulleyJP . Chronic blepharitis and dry eyes. International Ophthalmology Clinics1987;27(1):27-35.">Bowman 1987</a>). MGD seems to be more common in fair‐skinned individuals, but this may be due to its association with acne rosacea, which is also more prevalent in this population (<a href="./references#CD013697-bbs2-0039" title="DriverPJ , LempMA . Meibomian gland dysfunction. Survey of Ophthalmology1996;40(5):343-67.">Driver 1996</a>). Acne rosacea is characterized by skin telangiectasias (dilated superficial blood vessels), erythema, papules, and pustules; it was diagnosed in 20% of people with MGD in the <a href="./references#CD013697-bbs2-0055" title="McCulleyJP , DoughertyJM , DeneauDG . Classification of chronic blepharitis. Ophthalmology1982;89(10):1173-80.">McCulley 1982</a> study. In the same study, 46% of people with MGD were diagnosed with seborrhoeic dermatitis (<a href="./references#CD013697-bbs2-0055" title="McCulleyJP , DoughertyJM , DeneauDG . Classification of chronic blepharitis. Ophthalmology1982;89(10):1173-80.">McCulley 1982</a>). </p> <p>There are two species of the Demodex mite that are known to be associated with human eye and skin diseases: <i>Demodex folliculorum</i> and <i>Demodex brevis</i> . <i>D folliculorum</i> primarily infests the infundibulum of hair follicles, while <i>D brevis</i> infests the deeper sebaceous structures and meibomian glands (<a href="./references#CD013697-bbs2-0050" title="KabataşN , Doğan AŞ, KabataşEU , AcarM , BiçerT , GürdalC . The effect of Demodex infestation on blepharitis and the ocular symptoms. Eye and Contact Lens2017;43(1):64-7.">Kabatas 2017</a>). <i>Demodex</i> spp. are present in a quarter of the general population, and prevalence increases with age. Up to 100% of individuals over 70 years of age may have <i>Demodex</i> spp. present, leading to the assumption that it is commensal. However, there is a greater incidence of blepharitis in younger people who have the organism, and a higher number of mean organisms in people who have blepharitis (<a href="./references#CD013697-bbs2-0035" title="BiernatMM , Rusiecka-ZiolkowskaJ , PiakowksE , HelemejkoI , BiernatP . Occurrence of Demodex species in patients with blepharitis and in healthy individuals: a 10-year observational study. Japanese Journal of Ophthalmology2018;62(6):628-33.">Biernat 2018</a>). A meta‐analysis of studies in four countries showed a significant correlation between Demodex mite infestation and blepharitis (<a href="./references#CD013697-bbs2-0071" title="ZhaoYE , WuLP , HuL , XuJR . Association of blepharitis with Demodex: a meta-analysis. Ophthalmic Epidemiology2012;19(2):95-102.">Zhao 2012</a>). Blepharitis that has not responded to conventional treatments has been shown to improve with treatment of demodicosis. A recently published Cochrane Review evaluated the effects of tea tree oil on ocular <i>Demodex</i> infestation for people with Demodex blepharitis (<a href="./references#CD013697-bbs2-0065" title="SavlaK , LeJT , PuckerAD . Tea tree oil for Demodex blepharitis. Cochrane Database of Systematic Reviews2020, Issue 6. Art. No: CD013333. [DOI: 10.1002/14651858.CD013333.pub2]">Savla 2020</a>). It concluded that the effectiveness of 5% to 50% tea tree oil is uncertain for the short‐term treatment of Demodex blepharitis. </p> <p>In a study conducted in Florida in a cohort of people with any type of blepharitis, <a href="./references#CD013697-bbs2-0044" title="GrodenLR , MurphyB , RodniteJ , GenvertGI . Lid flora in blepharitis. Cornea1991;10(1):50-3.">Groden 1991</a> found the prevalence of acne rosacea to be 44% and the prevalence of KCS to be 30%. In an Austrian study of 407 people with chronic blepharitis, 14.5% of participants had KCS, 32.9% had seborrhoeic dermatitis, and 26.7% had acne rosacea (<a href="./references#CD013697-bbs2-0047" title="Huber-SpitzyV , BaumgartnerI , Böhler-SommereggerK , GrabnerG . Blepharitis—a diagnostic and therapeutic challenge. A report on 407 consecutive cases. Graefe's Archive for Clinical and Experimental Ophthalmology1991;229(3):224-7.">Huber‐Spitzy 1991</a>). </p> </section> <section id="CD013697-sec-0012"> <h4 class="title">Presentation and diagnosis</h4> <p>General symptoms of blepharitis include burning, itchiness, gritty feeling of the eyes, contact lens intolerance, and photophobia (light‐sensitivity). Symptoms are usually worse in the morning, and a person with blepharitis may have several exacerbations and remissions. </p> <p>Anterior blepharitis presents with redness and crusting of the eyelid margins. Specific examination of the eyelashes often reveals features such as poliosis (partial or total whitening of the lashes), madarosis (loss of eyelashes), trichiasis (misdirection of lashes towards the eye), and unusual features such as collarettes or dandruff‐like substances, which may all be helpful in diagnosing an etiologic pathogen. The eyelid skin or margin, or both, may be ulcerated or deformed in chronic cases. </p> <p>Staphylococcal blepharitis is characterized on examination by erythema and edema of the eyelid margin. Telangiectasia may be present on the anterior eyelid. Brittle scales may be seen in the eyelashes, and these may form collarettes, which encircle the lash at the base or further up as the lash grows. In severe and long‐standing cases, trichiasis, poliosis, madarosis, eyelid ulceration, and eyelid and corneal scarring may occur (<a href="./references#CD013697-bbs2-0033" title="American Academy of Ophthalmology Preferred Practice Pattern Cornea/External Disease Committee, Hoskins Center for Quality Eye Care. Blepharitis PPP-2018. www.aao.org/preferred-practice-pattern/blepharitis-ppp-2018 (accessed 4 June 2020).">AAO 2018</a>). </p> <p>Seborrhoeic blepharitis is differentiated by less erythema, edema, and telangiectasia of the lid margins compared to staphylococcal blepharitis, but an increased amount of oily scales and greasy crusting on the lashes (<a href="./references#CD013697-bbs2-0057" title="McCulleyJP , DoughertyJM . Blepharitis associated with acne rosacea and seborrheic dermatitis. International Ophthalmology Clinics1985;25(1):159-72.">McCulley 1985</a>). </p> <p>Posterior blepharitis may be seen clinically by examining the posterior eyelid margin. The meibomian glands may appear capped with oil, be dilated, or be visibly obstructed. Inflammation of the meibomian glands, termed 'meibomitis', may also be grossly observed during the examination in some cases, and may either be labelled as primary if with no other discernable cause, or secondary if deemed to be caused by nearby lesions such as lash base Demodex infestation. Meibomitis is an important clinical finding as if left untreated, it can cause inflammation of contacted ocular surface, leading to either an inflamed conjunctiva or cornea (meibomian keratoconjunctivitis). The secretions of the glands are usually turbid and thicker than normal. Telangiectasias and lid scarring may also be present in this area. In all forms of blepharitis, examination of the tear film may show instability and rapid evaporation. </p> <p>Clinical exam findings in MGD include prominent palpebral conjunctival vessels and a frothy discharge along the lid margins. The meibomian gland orifices in people with MGD often present as pouted or plugged, and manual expression may result in a fluid that ranges from turbid to "cheeselike" in consistency (<a href="./references#CD013697-bbs2-0055" title="McCulleyJP , DoughertyJM , DeneauDG . Classification of chronic blepharitis. Ophthalmology1982;89(10):1173-80.">McCulley 1982</a>). </p> <p>The presence of cylindrical dandruff along the eyelash base is highly correlated to Demodex mite infestation, and this must always be a consideration in cases of blepharitis. Diagnosis of Demodex mite infestation requires epilation of two to three lashes, and visualization of the Demodex mite during direct observation of the lash base using a high‐powered microscope (<a href="./references#CD013697-bbs2-0050" title="KabataşN , Doğan AŞ, KabataşEU , AcarM , BiçerT , GürdalC . The effect of Demodex infestation on blepharitis and the ocular symptoms. Eye and Contact Lens2017;43(1):64-7.">Kabatas 2017</a>; <a href="./references#CD013697-bbs2-0054" title="Lopez-PonceD , ZuazoF , CartesC , Salinas-ToroD , Perez-ValenzuelaC , ValenzuelaF , et al. High prevalence of Demodex spp. infestation among patients with posterior blepharitis: correlation with age and cylindrical dandruff [Alta prevncia de infestacion por Demodex spp. en pacientes con blefaritis posterior: correlacion con eded y caspa cilindrica]. Archivos de la Sociedad Espanola de Oftalmologia2017;92(9):e53-6.">Lopez‐Ponce 2017</a>). </p> </section> </section> <section id="CD013697-sec-0013"> <h3 class="title" id="CD013697-sec-0013">Description of the intervention</h3> <p>Although the pathophysiology of anterior and posterior blepharitis may be different, the treatment options are similar. Current practice is such that people are generally offered treatment if they report discomfort, have visual symptoms, or have grossly visible lid lesions which may include scarring secondary to chronic disease. Children must be paid particular attention, as they often do not report chronic discomfort and may instead present with a history of chronic recurrent conjunctivitis and chalazion (small to large lumps on the eyelid, caused by obstruction of the secretory glands). In these cases, treatment is initiated in order to prevent chronic irritative damage to the eye, which may result in suboptimal vision in the long term. The American Academy of Ophthalmology (AAO) Preferred Practice Pattern guidelines emphasize the need for detection of blepharitis, as there is a significant overlap between blepharitis and other clinical entities, especially tear film dysfunction (<a href="./references#CD013697-bbs2-0033" title="American Academy of Ophthalmology Preferred Practice Pattern Cornea/External Disease Committee, Hoskins Center for Quality Eye Care. Blepharitis PPP-2018. www.aao.org/preferred-practice-pattern/blepharitis-ppp-2018 (accessed 4 June 2020).">AAO 2018</a>). In such cases, a more customized treatment protocol may need to be developed to suit the person's unique requirements. Prior to treatment, it is important to inform the person that, although treatment may provide symptomatic relief, it may not necessarily cure the disease. A Cochrane Review of interventions for chronic blepharitis found that the available interventions did not show strong evidence for cure, and that long‐term monitoring may be necessary to provide optimal participant outcomes (<a href="./references#CD013697-bbs2-0072" title="LindsleyK , MatsumuraS , HatefE , AkpekEK . Interventions for chronic blepharitis. Cochrane Database of Systematic Reviews2012, Issue 5. Art. No: CD005556. [DOI: 10.1002/14651858.CD005556.pub2]">Lindsley 2012</a>). </p> <p>Oral tetracycline or doxycycline may be effective for people with posterior blepharitis or symptoms not adequately controlled by lid hygiene and topical medications, especially those with concurrent MGD (<a href="./references#CD013697-bbs2-0033" title="American Academy of Ophthalmology Preferred Practice Pattern Cornea/External Disease Committee, Hoskins Center for Quality Eye Care. Blepharitis PPP-2018. www.aao.org/preferred-practice-pattern/blepharitis-ppp-2018 (accessed 4 June 2020).">AAO 2018</a>). There are variations in clinical practice regarding the type and dosage of antibiotics for chronic blepharitis. Usual dosage can last from weeks to months. Clinical improvement requires several weeks, but once it is achieved, therapy may be discontinued or tapered to maintenance doses. The side effects of tetracycline may include raised intracranial hypertension, gastrointestinal disturbance, and skin hyperpigmentation. Furthermore, due to the affects on tooth and bone development, the drug has been assigned a Class D pregnancy category by the US Food and Drug Administration. </p> <p>Improvement in posterior blepharitis with tetracyclines may be related to inhibition of bacterial lipases in both <i>S aureus</i> and <i>S epidermidis</i> (<a href="./references#CD013697-bbs2-0038" title="DoughertyJM , McCulleyJP , SilvanyRE , MeyerDR . The role of tetracycline in chronic blepharitis. Inhibition of lipase production in staphylococci. Investigative Ophthalmology &amp; Visual Science1991;32(11):2970-5.">Dougherty 1991</a>). Oral minocycline, a broad‐spectrum tetracycline antibiotic, showed some benefit in treating MGD in two case series (<a href="./references#CD013697-bbs2-0034" title="AronowiczJD , ShineWE , OralD , VargasJM , McCulleyJP . Short term oral minocycline treatment of meibomianitis. British Journal of Ophthalmology2006;90(7):856-60.">Aronowicz 2006</a>; <a href="./references#CD013697-bbs2-0066" title="ShineWE , McCulleyJP , PandyaAG . Minocycline effect on meibomian gland lipids in meibomianitis patients. Experimental Eye Research2003;76(4):417-20.">Shine 2003</a>). However, it has shown side effects similar to other tetracyclines, such as photosensitivity, gastrointestinal disturbance, and hypersensitivity. In these cases, the AAO suggests the use of oral erythromycin as an alternative, particularly in children and pregnant women (<a href="./references#CD013697-bbs2-0033" title="American Academy of Ophthalmology Preferred Practice Pattern Cornea/External Disease Committee, Hoskins Center for Quality Eye Care. Blepharitis PPP-2018. www.aao.org/preferred-practice-pattern/blepharitis-ppp-2018 (accessed 4 June 2020).">AAO 2018</a>). The use of oral azithromycin was investigated for its efficacy as a viable alternative (<a href="./references#CD013697-bbs2-0070" title="ZandianM , RahimianN , SoheilifarS . Comparison of therapeutic effects of topical azithromycin solution and systemic doxycyline on posterior blepharitis. International Journal of Ophthalmology2016;9(7):1016-9.">Zandian 2016</a>). Tetracyclines such as doxycycline have the additional advantage of reducing dry eye symptoms by inducing tear production and reducing MGD, even though all the above‐mentioned drugs have similar effects in relieving subjective symptoms. A Cochrane Review on rosacea describes several drugs that may have potential use in the treatment of blepharitis, such as azelaic acid, brimonidine, and isotretinoin, but these have yet to be adequately investigated as treatments for blepharitis (<a href="./references#CD013697-bbs2-0068" title="vanZuurenEJ , FedorowiczZ , CarterB , van derLindenMM , CharlandL . Interventions for rosacea. Cochrane Database of Systematic Reviews2015, Issue 4. Art. No: CD003262. [DOI: 10.1002/14651858.CD003262.pub5]">van Zuuren 2015</a>). </p> </section> <section id="CD013697-sec-0014"> <h3 class="title" id="CD013697-sec-0014">How the intervention might work</h3> <p>Current therapeutic options for chronic blepharitis aim to resolve symptoms, maintain comfort, and prevent complications that may result in suboptimal vision (<a href="./references#CD013697-bbs2-0033" title="American Academy of Ophthalmology Preferred Practice Pattern Cornea/External Disease Committee, Hoskins Center for Quality Eye Care. Blepharitis PPP-2018. www.aao.org/preferred-practice-pattern/blepharitis-ppp-2018 (accessed 4 June 2020).">AAO 2018</a>; <a href="./references#CD013697-bbs2-0062" title="PflugfelderSC , KarpeckiPM , PerezVL . Treatment of blepharitis: recent clinical trials. Ocular Surface2014;12(4):273-84.">Pflugfelder 2014</a>). In most people with chronic blepharitis, inflammation and dry eye disease is complicated by the existence of abnormal commensals, either in the form of bacteria or <i>Demodex</i> spp. mites. The eradication of these pathogenic factors aids the restoration of the normal lid and glandular microenvironment (<a href="./references#CD013697-bbs2-0033" title="American Academy of Ophthalmology Preferred Practice Pattern Cornea/External Disease Committee, Hoskins Center for Quality Eye Care. Blepharitis PPP-2018. www.aao.org/preferred-practice-pattern/blepharitis-ppp-2018 (accessed 4 June 2020).">AAO 2018</a>; <a href="./references#CD013697-bbs2-0053" title="LiuJ , ShehaH , TsengSC . Pathogenic role of Demodex mites in blepharitis. Current Opinion in Allergy and Clinical Immunology2010;10(5):505-10.">Liu 2010</a>). Oral antibiotics help to eradicate the underlying infectious etiology, and may help to reduce inflammation. </p> </section> <section id="CD013697-sec-0015"> <h3 class="title" id="CD013697-sec-0015">Why it is important to do this review</h3> <p>Blepharitis is a common chronic disease whose etiology is poorly understood. The AAO Preferred Practice Pattern guidelines rate the strength of evidence to support oral tetracyclines for more severe and chronic cases as level III, a consensus opinion in the absence of substantial controlled evidence (<a href="./references#CD013697-bbs2-0033" title="American Academy of Ophthalmology Preferred Practice Pattern Cornea/External Disease Committee, Hoskins Center for Quality Eye Care. Blepharitis PPP-2018. www.aao.org/preferred-practice-pattern/blepharitis-ppp-2018 (accessed 4 June 2020).">AAO 2018</a>). Additionally, since the literature search by the AAO encompassed only English‐language articles published between 1997 and 2017, a more complete systematic approach is warranted to identify trials and to highlight any evidence gaps in the literature. This review focused on the evidence to support oral antibiotics for chronic blepharitis. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD013697-sec-0016" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD013697-sec-0016"></div> <p>To assess the benefits and harms of oral antibiotic use for people with chronic blepharitis.</p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD013697-sec-0017" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD013697-sec-0017"></div> <section id="CD013697-sec-0018"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD013697-sec-0019"> <h4 class="title">Types of studies</h4> <p>We included only randomized controlled trials (RCTs).</p> </section> <section id="CD013697-sec-0020"> <h4 class="title">Types of participants</h4> <p>We included trials in which participants were adults aged 16 years or older who were clinically diagnosed with chronic blepharitis, inclusive of staphylococcal, seborrhoeic, or MGD. We included adults only, as dosage for antibiotics varies between children and adults and did not provide an appropriately uniform comparator. As there are no standardized diagnostic protocols for chronic blepharitis or for the three subtypes, we also included studies where the type of chronic blepharitis was not specified, and studies that categorized chronic blepharitis using a different classification (e.g. meibomitis, primary meibomitis, meibomian keratoconjunctivitis). We included studies where participants with chronic blepharitis were a subset of the participants included in the study, if outcomes were reported separately for these participants. As many etiologies of chronic blepharitis have an inflammatory component, either locally (e.g. ocular adnexae) or systemically in dermatologic conditions (e.g. atopy or rosacea), many of these individuals are often treated with corticosteroid, either applied topically over the lids, or orally in the case of systemic involvement. We thus adjusted our search to include studies wherein additional treatment with antibiotics was compared to treatment without antibiotics in chronic blepharitis patients given corticosteroids for inflammation control. </p> </section> <section id="CD013697-sec-0021"> <h4 class="title">Types of interventions</h4> <p>We included studies that made the following comparisons:</p> <p> <ol id="CD013697-list-0001"> <li> <p>oral antibiotics versus placebo or no treatment;</p> </li> <li> <p>oral antibiotics with corticosteroids versus corticosteroids alone.</p> </li> </ol> </p> </section> <section id="CD013697-sec-0022"> <h4 class="title">Types of outcome measures</h4> <p>We included all relevant studies when we determined eligibility of studies for this review, irrespective of whether outcomes were reported. </p> <section id="CD013697-sec-0023"> <h5 class="title">Primary outcomes</h5> <p>Subjective improvement in symptoms, as judged by participant symptom report and measured by questionnaire, interview, or visual analogue scale (VAS), including but not limited to: irritation, burning, tearing, itching, eyelid sticking, photophobia, and increased frequency of blinking. </p> <p>Since there were no standardized diagnostic criteria for blepharitis and no standardized scales on which to judge symptom severity, clinical improvement in symptoms was expected to vary among studies. Although studies should ideally use validated scales, all reported scales were considered for inclusion since standardized information was unavailable. </p> </section> <section id="CD013697-sec-0024"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD013697-list-0002"> <li> <p>Measurements of eradication or decrease in the numbers of colonies of positive cultures of bacteria </p> </li> <li> <p>Clinical signs, including the following:</p> <ol id="CD013697-list-0003"> <li> <p>aqueous tear production, measured by the mean change in Schirmer's test scores (mm/5 min) performed with or without topical ocular anesthesia; </p> </li> <li> <p>tear film stability, measured by the mean change in tear film break‐up time (TBUT) (seconds); </p> </li> <li> <p>ocular surface evaluation using physician's assessment and documentation by ocular surface staining score. </p> </li> </ol> </li> <li> <p>Adverse events, measured by participant report or changes in clinical findings</p> </li> <li> <p>Quality of life measures</p> </li> <li> <p>Economic costs and benefits of different interventions</p> </li> </ol> </p> <section id="CD013697-sec-0025"> <h6 class="title">Follow‐up time points</h6> <p>We planned that the time points for all outcomes would be one month, three months, and six months after treatment initiation. The ranges of follow‐up time points were from one month to three months in this review. </p> </section> </section> </section> </section> <section id="CD013697-sec-0026"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD013697-sec-0027"> <h4 class="title">Electronic searches</h4> <p>The Cochrane Eyes and Vision Information Specialist searched the following electronic databases for RCTs and controlled clinical trials. There were no language or publication year restrictions. We last searched the electronic databases on 29 August 2020. </p> <p> <ul id="CD013697-list-0004"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2020, Issue 8) (which contains the Cochrane Eyes and Vision Trials Register) in the Cochrane Library (searched 29 August 2020) (<a href="./appendices#CD013697-sec-0075">Appendix 1</a>). </p> </li> <li> <p>MEDLINE Ovid (1946 to 29 August 2020) (<a href="./appendices#CD013697-sec-0076">Appendix 2</a>). </p> </li> <li> <p>Embase.com (1947 to 29 August 2020) (<a href="./appendices#CD013697-sec-0077">Appendix 3</a>). </p> </li> <li> <p>PubMed (1946 to 29 August 2020) (<a href="./appendices#CD013697-sec-0078">Appendix 4</a>). </p> </li> <li> <p>LILACS (Latin American and Caribbean Health Science Information database) (1982 to 29 August 2020) (<a href="./appendices#CD013697-sec-0079">Appendix 5</a>). </p> </li> <li> <p>US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>; searched 29 August 2020) (<a href="./appendices#CD013697-sec-0080">Appendix 6</a>). </p> </li> <li> <p>World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (<a href="http://www.who.int/ictrp" target="_blank">www.who.int/ictrp</a>; searched 29 August 2020) (<a href="./appendices#CD013697-sec-0081">Appendix 7</a>). </p> </li> </ul> </p> </section> <section id="CD013697-sec-0028"> <h4 class="title">Searching other resources</h4> <p>We searched the reference lists of reports from trials we identified for additional trials. We contacted experts in the field for information on current, past, or unpublished trials. We did not conduct manual searches of conference proceedings or abstracts specifically for this review. </p> </section> </section> <section id="CD013697-sec-0029"> <h3 class="title" id="CD013697-sec-0029">Data collection and analysis</h3> <p>We followed standard Cochrane methodology as described in our protocol.</p> <section id="CD013697-sec-0030"> <h4 class="title">Selection of studies</h4> <p>Two review authors (NO, SN) independently assessed the search results for potentially relevant trials based on our eligibility criteria (see <a href="#CD013697-sec-0018">Criteria for considering studies for this review</a>), as defined in our published protocol. We obtained full‐text copies of all reports that were assessed as potentially eligible by at least one review author. Two review authors (NO, SN) independently reviewed the full‐text copies for inclusion in the review. We documented reports excluded at this stage, and noted the reasons for their exclusion. Any discrepancies were resolved by consensus. </p> </section> <section id="CD013697-sec-0031"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (NO, SN) independently extracted data from the reports of eligible trials onto data extraction forms. We extracted the following study characteristics: methods, participants, interventions, and outcomes. We included any relevant data, such as source of study funding and any conflicts of interest stated by the investigators, in the 'notes' category. We presented these study characteristics in table format. One review author (SN) entered the data into Review Manager 5 (<a href="./references#CD013697-bbs2-0063" title="Review Manager 5 (RevMan 5). Version 5.4. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2020.">Review Manager 2020</a>), and a second review author (NO) verified the data entered. Any discrepancies were resolved by discussion. We extracted continuous and dichotomous data that were pertinent to the outcomes described in this protocol. </p> </section> <section id="CD013697-sec-0032"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (NO, SN) independently assessed risk of bias in the included trials according to the methods in Chapter 8 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD013697-bbs2-0045" title="HigginsJPT , AltmanDG , SterneJAC , editor(s). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). Cochrane, 2017. Available from training.cochrane.org/handbook/archive/v5.2.">Higgins 2017</a>). We based our assessment of studies on six domains: </p> <p> <ol id="CD013697-list-0005"> <li> <p>selection bias (sequence generation and allocation concealment);</p> </li> <li> <p>performance bias (masking of participants and researchers);</p> </li> <li> <p>detection bias (masking of those responsible for assessing outcomes);</p> </li> <li> <p>attrition bias (rates of follow‐up between groups and intention‐to‐treat (ITT) analysis);</p> </li> <li> <p>reporting bias (selective outcome reporting).</p> </li> </ol> </p> <p>For each risk of bias domain, two review authors (NO, SN) independently judged a given study to have a low, high, or unclear risk of bias. We presented descriptive documentation of the details of each parameter for each study in table format. We attempted to contact trial authors when additional data were necessary to evaluate bias, or when we judged the risk of bias to be unclear. However, we judged the parameter on the information available as we received no response to our request from the trial authors of one study, and we were unable to contact the trial authors for two studies. </p> </section> <section id="CD013697-sec-0033"> <h4 class="title">Measures of treatment effect</h4> <p>We reported the mean difference (MD) and associated 95% confidence intervals (95% CI) for all continuous outcomes and rating scales. We planned to report the standardized mean difference (SMD) if the included studies reported the same outcomes but on different valid rating scales. We reported risk ratios (RR) and the relevant 95% CI for all dichotomous outcomes, including any rating scales that were dichotomized based on a clinically relevant cut‐off point. </p> </section> <section id="CD013697-sec-0034"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis was the individual. Randomized cross‐over designs were inappropriate for this research question due to the risk of carry‐over effects and the possibility of period effects, and were thus excluded. </p> <p>In future updates, if a study randomizes participants to a study intervention that is applied to both eyes, and performs the analysis separately by eye, we will classify the study as a cluster‐randomized study. For studies in which each eye of a participant receives a different study intervention, the unit of analysis should be the eye (intracomparative). In such situations, we will extract and include the data in our analyses only when the study has correctly taken the intraperson correlation into account in their analyses. If we include any multi‐arm studies, we will analyze them appropriately by splitting the control group into two or more groups. </p> </section> <section id="CD013697-sec-0035"> <h4 class="title">Dealing with missing data</h4> <p>We attempted to contact study authors for additional information when data were missing or incomplete. We set the response time to two weeks; we used the data available in the published report as we either did not receive any reply in that time or were unable to contact study authors. </p> </section> <section id="CD013697-sec-0036"> <h4 class="title">Assessment of heterogeneity</h4> <p>We did not assess the between‐study heterogeneity.</p> <p>In future updates, we will assess clinical and methodological heterogeneity by examining variabilities in design, risk of bias, characteristics of participants, interventions, and outcomes among the included studies. We will perform the Chi<sup>2</sup> test and use the I<sup>2</sup> statistic to identify heterogeneity. We will interpret an I<sup>2</sup> greater than 50% as representing substantial heterogeneity. </p> </section> <section id="CD013697-sec-0037"> <h4 class="title">Assessment of reporting biases</h4> <p>We planned to examine the symmetry of funnel plots to assess reporting biases if we could include 10 or more studies in a meta‐analysis. We did not examine the symmetry of funnel plots because we included two studies only. </p> </section> <section id="CD013697-sec-0038"> <h4 class="title">Data synthesis</h4> <p>We qualitatively synthesized the current evidence based on the included studies.</p> <p>In future updates, we will conduct meta‐analyses of studies with comparable outcomes and timing of outcomes if we judge the participants, interventions, and outcomes to be sufficiently similar. If there are fewer than three studies in a meta‐analysis and we do not detect any heterogeneity, we will use a fixed‐effect model. Otherwise, we will use a random‐effects model. We will document study results that are not compatible for meta‐analysis, and summarize the overall treatment effects as reported by each study. </p> </section> <section id="CD013697-sec-0039"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We did not perform any subgroup analysis in this review. If sufficient data are provided in future updates, we will conduct subgroup analysis by analyzing anterior and posterior blepharitis separately, according to the classifications provided by the authors of the included studies. </p> </section> <section id="CD013697-sec-0040"> <h4 class="title">Sensitivity analysis</h4> <p>We did not perform any sensitivity analysis. If sufficient data are available in future updates, we will conduct sensitivity analyses to examine the impact of excluding unpublished studies, industry‐funded studies, and studies with lower methodological quality. </p> </section> <section id="CD013697-sec-0041"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We prepared a summary of findings table comparing oral antibiotics versus placebo which presented the following six outcomes (<a href="./full#CD013697-tbl-0001">summary of findings Table 1</a>). </p> <p> <ol id="CD013697-list-0006"> <li> <p>Subjective improvement in symptoms</p> </li> <li> <p>Measurements of eradication or decrease in numbers of colonies of positive cultures of bacteria </p> </li> <li> <p>Clinical signs</p> </li> <li> <p>Adverse events</p> </li> <li> <p>Quality of life measures</p> </li> <li> <p>Economic costs and benefits of different interventions</p> </li> </ol> </p> <p>Two review authors (NO, SN) independently graded the certainty of the body of evidence for each outcome with a 4‐level rating scale (i.e. high, moderate, low, or very low) using the GRADE classification. Any disagreements were resolved by discussion and obtaining consensus within the review team. We downgraded the quality level of a body of evidence based on the following factors: </p> <p> <ol id="CD013697-list-0007"> <li> <p>high risk of bias among included studies;</p> </li> <li> <p>indirectness of evidence;</p> </li> <li> <p>unexplained heterogeneity or inconsistency of results;</p> </li> <li> <p>imprecision of results;</p> </li> <li> <p>high probability of publication bias.</p> </li> </ol> </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD013697-sec-0042" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD013697-sec-0042"></div> <section id="CD013697-sec-0043"> <h3 class="title">Description of studies</h3> <p>A study flow diagram is shown in <a href="#CD013697-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD013697-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD013697-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/image_n/nCD013697-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <section id="CD013697-sec-0044"> <h4 class="title">Results of the search</h4> <p>Our search of the electronic databases on 29 August 2020 yielded 4382 records. After removing duplicates, we screened 3754 titles and abstracts. We retrieved 32 full‐text reports for further review. After full‐text screening, we excluded 28 studies (28 records) with reasons; identified two ongoing studies (two records); and included two studies (two records) in the review. </p> <p>One of the ongoing studies started in 2015, and the findings have not been published yet (<a href="./references#CD013697-bbs2-0031" title="ChiCTR-IPC-150067. Azithromycin and doxycycline in the management of meibomian gland dysfunction. www2.ccrb.cuhk.edu.hk/registry/public/302 (first received 6 July 2015). ">ChiCTR‐IPC‐15006715</a>); the other ongoing study started in 2019, with an estimated completion date of December 2019 (<a href="./references#CD013697-bbs2-0032" title="NCT03953118. Azithromycin for meibomian gland disease [A randomized, controlled trial to evaluate the role of oral azithromycin in the treatment of symptomatic meibomian gland disease and its effect on the ocular surface microbiome]. clinicaltrials.gov/ct2/show/NCT03953118 (first received 16 May 2019). ">NCT03953118</a>). </p> </section> <section id="CD013697-sec-0045"> <h4 class="title">Included studies</h4> <p>We included two studies with a total of 220 randomized participants. The numbers of eyes enrolled were unclear as the manner in which the study eye was chosen (e.g. average of two eyes, or one eye) was not reported. For details of the included studies, see <a href="./references#CD013697-sec-0090" title="">Characteristics of included studies</a>. </p> <p>One parallel‐group RCT comparing oral doxycycline (40 mg once a day) with placebo enrolled 70 participants with blepharitis and facial rosacea in eight clinics in the USA (<a href="./references#CD013697-bbs2-0001" title="NCT00560703. Treatment of patients with blepharitis and facial rosacea [Efficacy and safety of COL-101 for the treatment of blepharitis in patients with facial rosacea]. clinicaltrials.gov/ct2/show/NCT00560703 (first received 20 November 2007). ">NCT00560703</a>). Changes in bulbar conjunctival hyperemia and Ocular Surface Disease Index (OSDI) scores were reported after the study period of 12 weeks. This study was funded by industry. </p> <p>One three‐arm RCT investigated the effect of high‐dose (200 mg twice a day) and low‐dose (20 mg twice a day) doxycycline versus placebo (<a href="./references#CD013697-bbs2-0002" title="YooSE , LeeDC , ChangMH . The effect of low-dose doxycycline therapy in chronic meibomian gland dysfunction. Korean Journal of Ophthalmology2005;19(4):258-63. ">Yoo 2005</a>). It enrolled 50 participants with chronic meibomian gland dysfunction (MGD) in each arm (i.e. 150 participants in total) in South Korea. Subjective symptoms, Schirmer's test, and tear film break‐up time (TBUT) were measured after one month of study medication. This study failed to present sources of funding and conflicts of interest. </p> </section> <section id="CD013697-sec-0046"> <h4 class="title">Excluded studies</h4> <p>We excluded 28 studies after full‐text review, and listed the reasons for exclusion in the <a href="./references#CD013697-sec-0091" title="">Characteristics of excluded studies</a> table. In summary, we excluded 14 studies based on study design (non‐RCTs or cross‐over trials), 11 studies on the interventions assessed (e.g. topical rather than oral antibiotics), and two studies due to ineligible study populations. We excluded one RCT that was terminated before enrollment. </p> </section> </section> <section id="CD013697-sec-0047"> <h3 class="title">Risk of bias in included studies</h3> <p>Risk of bias assessment for each included study is described in the <a href="./references#CD013697-sec-0090" title="">Characteristics of included studies</a> table. A summary of risk of bias assessments is shown in <a href="#CD013697-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD013697-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD013697-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/image_n/nCD013697-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD013697-sec-0048"> <h4 class="title">Allocation</h4> <p>Neither of the included studies described the method for allocation sequence generation and allocation concealment before assignment. We therefore judged the risk of selection bias to be unclear for both included studies. </p> </section> <section id="CD013697-sec-0049"> <h4 class="title">Blinding</h4> <p>We judged both included studies as having a low risk of performance bias because in both studies participants and personnel were masked to intervention assignment. Outcome assessors were masked to the assignment in one study, which we assessed as at low risk of detection bias (<a href="./references#CD013697-bbs2-0001" title="NCT00560703. Treatment of patients with blepharitis and facial rosacea [Efficacy and safety of COL-101 for the treatment of blepharitis in patients with facial rosacea]. clinicaltrials.gov/ct2/show/NCT00560703 (first received 20 November 2007). ">NCT00560703</a>). We judged the other included study as having an unclear risk of detection bias, as information on masking of outcome assessors was insufficient to permit a judgement of low or high risk of bias (<a href="./references#CD013697-bbs2-0002" title="YooSE , LeeDC , ChangMH . The effect of low-dose doxycycline therapy in chronic meibomian gland dysfunction. Korean Journal of Ophthalmology2005;19(4):258-63. ">Yoo 2005</a>). </p> </section> <section id="CD013697-sec-0050"> <h4 class="title">Incomplete outcome data</h4> <p>We judged one study in which there were no missing outcome data as at low risk of attrition bias (<a href="./references#CD013697-bbs2-0001" title="NCT00560703. Treatment of patients with blepharitis and facial rosacea [Efficacy and safety of COL-101 for the treatment of blepharitis in patients with facial rosacea]. clinicaltrials.gov/ct2/show/NCT00560703 (first received 20 November 2007). ">NCT00560703</a>). We judged the other study as having a high risk of attrition bias because 11 (7.3%) of randomized participants were not included in the final analysis (<a href="./references#CD013697-bbs2-0002" title="YooSE , LeeDC , ChangMH . The effect of low-dose doxycycline therapy in chronic meibomian gland dysfunction. Korean Journal of Ophthalmology2005;19(4):258-63. ">Yoo 2005</a>). </p> </section> <section id="CD013697-sec-0051"> <h4 class="title">Selective reporting</h4> <p>Secondary outcomes that were originally presented in the trial registry were not presented in the final report in one study (<a href="./references#CD013697-bbs2-0001" title="NCT00560703. Treatment of patients with blepharitis and facial rosacea [Efficacy and safety of COL-101 for the treatment of blepharitis in patients with facial rosacea]. clinicaltrials.gov/ct2/show/NCT00560703 (first received 20 November 2007). ">NCT00560703</a>), which we judged as at high risk of reporting bias. We judged the other study as at unclear risk of reporting bias because neither protocol nor trial registry was available for this study (<a href="./references#CD013697-bbs2-0002" title="YooSE , LeeDC , ChangMH . The effect of low-dose doxycycline therapy in chronic meibomian gland dysfunction. Korean Journal of Ophthalmology2005;19(4):258-63. ">Yoo 2005</a>). </p> </section> </section> <section id="CD013697-sec-0052"> <h3 class="title" id="CD013697-sec-0052">Effects of interventions</h3> <p>See: <a href="./full#CD013697-tbl-0001"><b>Summary of findings 1</b> Oral antibiotics compared with placebo for chronic blepharitis</a> </p> <p>We did not conduct any meta‐analysis or assess between‐study heterogeneity because the two included studies did not evaluate the same outcome measurements. </p> <section id="CD013697-sec-0053"> <h4 class="title">Primary outcomes</h4> <section id="CD013697-sec-0054"> <h5 class="title">Subjective improvement in symptoms</h5> <p><a href="./references#CD013697-bbs2-0001" title="NCT00560703. Treatment of patients with blepharitis and facial rosacea [Efficacy and safety of COL-101 for the treatment of blepharitis in patients with facial rosacea]. clinicaltrials.gov/ct2/show/NCT00560703 (first received 20 November 2007). ">NCT00560703</a> compared oral doxycycline (46 participants) with placebo (24 participants) and measured a subjective outcome based on the OSDI. Mean OSDI scores at 12 weeks postintervention decreased on average 5.15 (standard deviation (SD) 14.0) in the oral antibiotics group and 8.70 (SD 17.7) in the placebo group. The estimated mean difference (MD) between interventions was 3.55 (95% confidence interval (CI) −4.61 to 11.71; n = 70) (<a href="./references#CD013697-fig-0003" title="">Analysis 1.1</a>). Bulbar conjunctival hyperemia was also evaluated by using an ordinal variable ranging from 0 (clear) to 4 (severe). The mean change in bulbar conjunctival hyperemia after 12 weeks was −0.61 (SD 0.80) and −0.60 (SD 0.71) in the oral doxycycline and placebo groups, respectively. The estimated MD showed little to no difference between intervention groups (MD −0.01, 95% CI −0.38 to 0.36; n = 70) (<a href="./references#CD013697-fig-0004" title="">Analysis 1.2</a>). </p> <p><a href="./references#CD013697-bbs2-0002" title="YooSE , LeeDC , ChangMH . The effect of low-dose doxycycline therapy in chronic meibomian gland dysfunction. Korean Journal of Ophthalmology2005;19(4):258-63. ">Yoo 2005</a> evaluated subjective symptoms by measuring the number of symptoms and proportion of participants with improvement. After one month of interventions, the mean number of symptoms decreased from 2.33 (SD 0.97) to 1.45 (SD 0.62) in the high‐dose doxycycline group (46 participants) and from 2.92 (SD 0.77) to 1.53 (SD 0.52) in the low‐dose doxycycline group (46 participants), compared with little to no change from 2.1 (SD 1.06) to 2.01 (1.23) in the placebo group (47 participants). The estimated MD in number of symptoms between groups at one month was −0.56 (95% CI −0.95 to −0.17; n = 93) between the high‐dose doxycycline and placebo groups, and MD −0.48 (95% CI −0.86 to −0.10; n = 93) between the low‐dose doxycycline and placebo groups, in favor of the oral doxycycline groups (<a href="./references#CD013697-fig-0005" title="">Analysis 1.3</a>). After one month, 30 (65.2%) of 46 participants in the high‐dose doxycycline group and 32 (69.6%) of 46 participants in the low‐dose doxycycline group experienced subjective improvement in symptoms compared with 5 (10.6%) of 47 participants in the placebo group. The estimated risk ratio (RR) for improvement in subjective symptoms was 6.13 (95% CI 2.61 to 14.42; n = 93) in the high‐dose doxycycline group compared to the placebo group, and 6.54 (95% CI 2.79 to 15.30; n = 93) in the low‐dose doxycycline group compared to the placebo group, both in favor of oral doxycycline (<a href="./references#CD013697-fig-0006" title="">Analysis 1.4</a>). </p> <p>We judged the certainty of the evidence for subjective symptoms as very low, downgrading one level for high risk of bias (−1), one level for imprecision due to wide confidence intervals (−1), and one level for inconsistency of results (−1). </p> </section> </section> <section id="CD013697-sec-0055"> <h4 class="title">Secondary outcomes</h4> <section id="CD013697-sec-0056"> <h5 class="title">Measurements of eradication or decrease in numbers of colonies of positive cultures of bacteria </h5> <p>Neither of the included studies measured this outcome.</p> </section> <section id="CD013697-sec-0057"> <h5 class="title">Clinical signs: Schirmer's test scores (mm/5 min)</h5> <p>One study evaluated the aqueous tear production by the Schirmer's test (<a href="./references#CD013697-bbs2-0002" title="YooSE , LeeDC , ChangMH . The effect of low-dose doxycycline therapy in chronic meibomian gland dysfunction. Korean Journal of Ophthalmology2005;19(4):258-63. ">Yoo 2005</a>). Mean Schirmer's test scores (mm/5 minutes) increased to 19.98 mm (SD 4.05) after one month of treatment from 18.13 mm (SD 3.87) in the high‐dose doxycycline group (MD 1.85 mm, 95% CI 0.23 to 3.47; n = 46) and increased to 19.65 mm (SD 5.02) from 17.27 mm (SD 4.16) in the low‐dose doxycycline group (MD 2.38 mm, 95% CI 0.50 to 4.26; n = 46), whereas little to no improvement was observed in the control group (16.57 mm at baseline and 15.89 mm at one month; MD −0.68 mm, 95% CI −2.45 to 1.09; n = 47). The estimated MD in Schirmer's test score between groups after one month of treatment was 4.09 mm (95% CI 2.38 to 5.80; n = 93) in the high‐dose doxycycline group versus the placebo group and 3.76 mm (95% CI 1.85 to 5.67; n = 93) in the low‐dose doxycycline group versus the placebo group (<a href="./references#CD013697-fig-0007" title="">Analysis 1.5</a>). </p> <p>We judged the certainty of the evidence for this outcome as very low, downgrading one level for high risk of bias (−1) and two levels for imprecision due to wide confidence intervals (−2). </p> </section> <section id="CD013697-sec-0058"> <h5 class="title">Clinical signs: tear film break‐up time (seconds)</h5> <p>Yoo and colleagues assessed the tear film stability by measuring TBUT (seconds) after one month of the study period (<a href="./references#CD013697-bbs2-0002" title="YooSE , LeeDC , ChangMH . The effect of low-dose doxycycline therapy in chronic meibomian gland dysfunction. Korean Journal of Ophthalmology2005;19(4):258-63. ">Yoo 2005</a>). After one month, mean TBUT scores improved from 7.78 to 9.42 seconds (MD 1.64, 95% CI 0.62 to 2.66; n = 46) in the high‐dose doxycycline group, and from 7.82 to 9.54 seconds (MD 1.72, 95% CI 0.95 to 2.49; n = 46) in the low‐dose doxycycline group, although mean TBUT showed little to no improvement, from 7.80 to 7.84, in the placebo group (MD 0.04, 95% CI −0.80 to 0.88; n = 47). The estimated MD in TBUT between groups after one month was 1.58 seconds (95% CI 0.57 to 2.59; n = 93) when comparing the high‐dose doxycycline and placebo groups, and 1.70 seconds (95% CI 0.96 to 2.44; n = 93) when comparing the low‐dose doxycycline and placebo groups (<a href="./references#CD013697-fig-0008" title="">Analysis 1.6</a>). However, this study reported that no evidence of difference was found between low‐ and high‐dose doxycycline groups (P = 0.992; analysis of variance (ANOVA)). </p> <p>We judged the certainty of the evidence for this outcome as very low, downgrading one level for high risk of bias (−1) and two levels for imprecision due to wide confidence intervals (−2). </p> </section> <section id="CD013697-sec-0059"> <h5 class="title">Clinical signs: ocular surface staining score</h5> <p>Neither of the included studies measured this outcome.</p> </section> <section id="CD013697-sec-0060"> <h5 class="title">Adverse events</h5> <p>In <a href="./references#CD013697-bbs2-0001" title="NCT00560703. Treatment of patients with blepharitis and facial rosacea [Efficacy and safety of COL-101 for the treatment of blepharitis in patients with facial rosacea]. clinicaltrials.gov/ct2/show/NCT00560703 (first received 20 November 2007). ">NCT00560703</a>, 1 (2.17%) participant experienced migraine headache (severe adverse event), and 5 (10.87%) participants reported headache in the oral doxycycline group, while 1 (4.17%) participant had non‐Hodgkin's lymphoma (severe adverse event) in the placebo group during the treatment period of 12 weeks. </p> <p>In <a href="./references#CD013697-bbs2-0002" title="YooSE , LeeDC , ChangMH . The effect of low-dose doxycycline therapy in chronic meibomian gland dysfunction. Korean Journal of Ophthalmology2005;19(4):258-63. ">Yoo 2005</a>, serious side effects were observed in 18 of 46 participants in the high‐dose doxycycline group, 8 of 46 participants in the low‐dose doxycycline group, and 3 of 47 participants in the placebo group (RR 6.13, 95% CI 1.94 to 19.41; n = 93 (high‐dose doxycycline versus placebo); RR 2.72, 95% CI 0.77 to 9.64; n = 93 (low‐dose doxycycline versus placebo)) (<a href="./references#CD013697-fig-0009" title="">Analysis 1.7</a>). The authors also reported that participants in the high‐dose doxycycline group tended to experience adverse events more frequently compared with those in low‐dose doxycycline group (P = 0.002; Chi<sup>2</sup> test). Four participants (8.7%) in the high‐dose doxycycline group, 2 (4.3%) in the low‐dose doxycycline group, and 1 (2.1%) in the placebo group withdrew from the study due to adverse events. Other common adverse events included gastrointestinal issues (e.g. dyspepsia, nausea, diarrhea) (21 participants), itchy skin, urticaria and erythematous papules (7 participants each), and stomatitis (1 participant). </p> <p>We judged the certainty of the evidence for adverse events as very low, downgrading one level for high risk of bias (−1) and two levels for imprecision due to wide confidence intervals (−2). </p> </section> <section id="CD013697-sec-0061"> <h5 class="title">Quality of life measures</h5> <p>Neither of the included studies evaluated quality of life measures.</p> </section> <section id="CD013697-sec-0062"> <h5 class="title">Economic costs and benefits of different interventions</h5> <p>Neither of the included studies evaluated the costs of the interventions compared.</p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD013697-sec-0063" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD013697-sec-0063"></div> <section id="CD013697-sec-0064"> <h3 class="title" id="CD013697-sec-0064">Summary of main results</h3> <p>This systematic review summarized the data from two RCTs reporting on the efficacy of the use of oral antibiotics for chronic blepharitis. Both studies used tetracycline antibiotics (doxycycline) (<a href="./references#CD013697-bbs2-0001" title="NCT00560703. Treatment of patients with blepharitis and facial rosacea [Efficacy and safety of COL-101 for the treatment of blepharitis in patients with facial rosacea]. clinicaltrials.gov/ct2/show/NCT00560703 (first received 20 November 2007). ">NCT00560703</a>; <a href="./references#CD013697-bbs2-0002" title="YooSE , LeeDC , ChangMH . The effect of low-dose doxycycline therapy in chronic meibomian gland dysfunction. Korean Journal of Ophthalmology2005;19(4):258-63. ">Yoo 2005</a>). The studies comprised a total of 220 participants from two countries, the USA and South Korea. </p> <p>The included studies examined different parameters in order to gauge effectiveness of treatment and, as such, a meta‐analysis was not performed. </p> <p>The primary outcome for the two studies included subjective improvement of symptoms, although the outcome measurements varied betw<a href="https://revman.cochrane.org/" target="_blank">• Summary of main results</a> een studies. Use of oral antibiotics showed favorable effects on subjective symptoms in one study (Yoo 2005). The use of high‐ and low‐dose antibiotics demonstrated a slightly lower mean number of symptoms compared to placebo after a one‐month course of oral antibiotics. The other study examined subjective symptoms by measuring the Ocular Surface Disease Index (OSDI) and bulbar conjunctival hyperemia in 70 participants with blepharitis and facial rosacea (NCT00560703). The estimated mean difference showed little to no difference between the oral antibiotics group and the placebo group in OSDI scores and in bulbar conjunctival hyperemia after 12 weeks. The confidence interval was consistent with no difference. The lack of an important difference in ocular manifestations associated with facial rosacea highlights the importance of testing ophthalmologic effects of treatment specifically. </p> <p>In Schirmer's testing, a mild improvement was noted in 46 participants treated with high‐dose doxycycline and in 46 participants treated with low‐dose doxycycline compared to the placebo control (<a href="./references#CD013697-bbs2-0002" title="YooSE , LeeDC , ChangMH . The effect of low-dose doxycycline therapy in chronic meibomian gland dysfunction. Korean Journal of Ophthalmology2005;19(4):258-63. ">Yoo 2005</a>). This study also found a mild improvement in TBUT after one month in both high‐ and low‐dose doxycycline groups when compared to placebo. There was little to no difference between low‐ and high‐dose doxycycline groups. Although Schirmer's test and TBUT showed improvement in scores, the clinical importance of this improvement remains uncertain. </p> <p>Adverse events were well documented in both studies. In <a href="./references#CD013697-bbs2-0001" title="NCT00560703. Treatment of patients with blepharitis and facial rosacea [Efficacy and safety of COL-101 for the treatment of blepharitis in patients with facial rosacea]. clinicaltrials.gov/ct2/show/NCT00560703 (first received 20 November 2007). ">NCT00560703</a>, one severe adverse event (migraine headache) was recorded. The study by <a href="./references#CD013697-bbs2-0002" title="YooSE , LeeDC , ChangMH . The effect of low-dose doxycycline therapy in chronic meibomian gland dysfunction. Korean Journal of Ophthalmology2005;19(4):258-63. ">Yoo 2005</a> reported that adverse events increased in a dose‐dependent fashion. The authors reported that participants in high‐dose doxycycline group tended to experience adverse events more frequently compared with those in low‐dose doxycycline group. Eighteen of 46 participants in the high‐dose doxycycline group, eight of 46 participants in the low‐dose doxycycline group, and three of 47 participants in the placebo group experienced serious side effects. Four (8.7%) participants in the high‐dose doxycycline group, two (4.3%) participants in the low‐dose doxycycline group and one (2.1%) participant in the placebo group withdrew the study due to adverse events. </p> <p>Neither of the included studies examined bacterial culture, ocular surface staining scores, quality of life measures, or economic cost and benefit. </p> <p>The overall efficacy of oral antibiotics for chronic blepharitis showed mixed and uncertain results. Although beneficial effects may have been noted as outlined above, these effects were minimal and may not justify long‐term exposure to antibiotics and the corresponding risk of side effects. </p> <p>The certainty of the evidence was very low due to high risk of bias and imprecision.</p> </section> <section id="CD013697-sec-0065"> <h3 class="title" id="CD013697-sec-0065">Overall completeness and applicability of evidence</h3> <p>The overall completeness and applicability of the evidence to address all of the objectives in this review are low. The included studies were geographically spread in the USA and Asia (South Korea), and the types of participants varied in conditions of chronic blepharitis (chronic blepharitis with facial rosacea and chronic meibomian gland dysfunction). However, although chronic blepharitis is a common ocular condition (affecting 37% to 47% of all ophthalmology patients seen based on a survey conducted in the USA) (<a href="./references#CD013697-bbs2-0052" title="LempMA , NicholsKK . Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment. Ocular Surface2009;7(Suppl 2):S1-14.">Lemp 2009</a>), we identified only two studies in this review, with relatively small sample sizes. With respect to interventions, only tetracycline was investigated in the included studies. In addition, the lack of standardized protocols for assessment of findings resulted in a wide variation of outcome measures between studies, hindering comparability. </p> <p>Given these issues, the data gathered from this review may not be generalizable regarding the use of oral antibiotics for chronic blepharitis.  </p> </section> <section id="CD013697-sec-0066"> <h3 class="title" id="CD013697-sec-0066">Quality of the evidence</h3> <p>We graded the certainty of the evidence for all outcomes as very low due to high risk of bias and for imprecision due to wide confidence intervals. </p> <p>There were limitations in study design and implementation in the included studies. In one study, 11 (7.3%) of randomized participants were excluded from the analysis, resulting in a judgement of high risk of attrition bias (<a href="./references#CD013697-bbs2-0002" title="YooSE , LeeDC , ChangMH . The effect of low-dose doxycycline therapy in chronic meibomian gland dysfunction. Korean Journal of Ophthalmology2005;19(4):258-63. ">Yoo 2005</a>) In the other study, secondary outcomes which were originally described in the trial registry were not presented in the final report (<a href="./references#CD013697-bbs2-0001" title="NCT00560703. Treatment of patients with blepharitis and facial rosacea [Efficacy and safety of COL-101 for the treatment of blepharitis in patients with facial rosacea]. clinicaltrials.gov/ct2/show/NCT00560703 (first received 20 November 2007). ">NCT00560703</a>). We judged this study as at high risk of reporting bias. Furthermore, each study had at least two risk of bias domains that were judged as unclear risk because information was insufficient to permit a judgement. </p> </section> <section id="CD013697-sec-0067"> <h3 class="title" id="CD013697-sec-0067">Potential biases in the review process</h3> <p>We followed standard Cochrane Review methods to minimize bias and Methodological Expectations of Cochrane Intervention Reviews (MECIR) standards for the reporting of new Cochrane Intervention Reviews (<a href="http://editorial-unit.cochrane.org/mecir" target="_blank">editorial-unit.cochrane.org/mecir</a>) in conducting this review. An Information Specialist performed highly sensitive searches to identify studies. None of the review authors has any financial conflicts of interest. </p> </section> <section id="CD013697-sec-0068"> <h3 class="title" id="CD013697-sec-0068">Agreements and disagreements with other studies or reviews</h3> <p>The findings of this study are consistent with the American Academy of Ophthalmology's Preferred Practice Guidelines for blepharitis and published literature (<a href="./references#CD013697-bbs2-0033" title="American Academy of Ophthalmology Preferred Practice Pattern Cornea/External Disease Committee, Hoskins Center for Quality Eye Care. Blepharitis PPP-2018. www.aao.org/preferred-practice-pattern/blepharitis-ppp-2018 (accessed 4 June 2020).">AAO 2018</a>; <a href="./references#CD013697-bbs2-0042" title="GeerlingG , TauberJ , BaudouinC , GotoE , MatsumotoY , O'BrienT , et al. The International Workshop on Meibomian Gland Dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. Investigative Ophthalmology &amp; Visual Science2011;52(4):2050-64.">Geerling 2011</a>; <a href="./references#CD013697-bbs2-0059" title="NelsonJD , ShimazakiJ , Benitez-del-CastilloJM , CraigJP , McCulleyJP , DenS , et al. The International Workshop on Meibomian Gland Dysfunction: Report of the Definition and Classification Subcommittee. Investigative Ophthalmology &amp; Visual Science2011;52(4):1930–7.">Nelson 2011</a>; <a href="./references#CD013697-bbs2-0068" title="vanZuurenEJ , FedorowiczZ , CarterB , van derLindenMM , CharlandL . Interventions for rosacea. Cochrane Database of Systematic Reviews2015, Issue 4. Art. No: CD003262. [DOI: 10.1002/14651858.CD003262.pub5]">van Zuuren 2015</a>). Based on very low certainty evidence, our analysis found mixed results with little to no difference between groups identified in one study, and a mild positive effect in the other study regarding symptom improvement with the use of oral antibiotics, yet a suggestive dose‐response relationship between oral doxycycline use and risks for adverse events. </p> <p>The authors of a previous systematic review assessed the efficacy and safety of oral antibiotics in facial rosacea‐associated chronic blepharitis (<a href="./references#CD013697-bbs2-0068" title="vanZuurenEJ , FedorowiczZ , CarterB , van derLindenMM , CharlandL . Interventions for rosacea. Cochrane Database of Systematic Reviews2015, Issue 4. Art. No: CD003262. [DOI: 10.1002/14651858.CD003262.pub5]">van Zuuren 2015</a>), and reported similarly inconclusive findings. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD013697-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/urn:x-wiley:14651858:media:CD013697:CD013697-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD013697-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/image_n/nCD013697-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/image_t/tCD013697-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/full#CD013697-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/image_n/nCD013697-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013697-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/urn:x-wiley:14651858:media:CD013697:CD013697-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD013697-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/image_n/nCD013697-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/image_t/tCD013697-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/full#CD013697-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/image_n/nCD013697-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013697-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/urn:x-wiley:14651858:media:CD013697:CD013697-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Oral antibiotics versus placebo, Outcome 1: Mean change in the Ocular Surface Disease Index at week 12" data-id="CD013697-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/image_n/nCD013697-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/image_t/tCD013697-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Oral antibiotics versus placebo, Outcome 1: Mean change in the Ocular Surface Disease Index at week 12 </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/references#CD013697-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/image_n/nCD013697-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013697-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/urn:x-wiley:14651858:media:CD013697:CD013697-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Oral antibiotics versus placebo, Outcome 2: Mean change in bulbar conjunctival hyperemia at week 12" data-id="CD013697-fig-0004" src="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/image_n/nCD013697-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/image_t/tCD013697-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Oral antibiotics versus placebo, Outcome 2: Mean change in bulbar conjunctival hyperemia at week 12 </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/references#CD013697-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/image_n/nCD013697-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013697-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/urn:x-wiley:14651858:media:CD013697:CD013697-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Oral antibiotics versus placebo, Outcome 3: Mean number of symptoms at month 1" data-id="CD013697-fig-0005" src="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/image_n/nCD013697-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/image_t/tCD013697-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Oral antibiotics versus placebo, Outcome 3: Mean number of symptoms at month 1 </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/references#CD013697-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/image_n/nCD013697-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013697-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/urn:x-wiley:14651858:media:CD013697:CD013697-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Oral antibiotics versus placebo, Outcome 4: Subjective improvement in symptoms at month 1" data-id="CD013697-fig-0006" src="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/image_n/nCD013697-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/image_t/tCD013697-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Oral antibiotics versus placebo, Outcome 4: Subjective improvement in symptoms at month 1 </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/references#CD013697-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/image_n/nCD013697-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013697-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/urn:x-wiley:14651858:media:CD013697:CD013697-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Oral antibiotics versus placebo, Outcome 5: Mean Schirmer's test score at month 1 (mm/5 min)" data-id="CD013697-fig-0007" src="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/image_n/nCD013697-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/image_t/tCD013697-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Oral antibiotics versus placebo, Outcome 5: Mean Schirmer's test score at month 1 (mm/5 min) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/references#CD013697-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/image_n/nCD013697-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013697-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/urn:x-wiley:14651858:media:CD013697:CD013697-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Oral antibiotics versus placebo, Outcome 6: Tear film break‐up time at month 1 (seconds) " data-id="CD013697-fig-0008" src="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/image_n/nCD013697-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/image_t/tCD013697-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: Oral antibiotics versus placebo, Outcome 6: Tear film break‐up time at month 1 (seconds)  </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/references#CD013697-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/image_n/nCD013697-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013697-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/urn:x-wiley:14651858:media:CD013697:CD013697-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Oral antibiotics versus placebo, Outcome 7: Adverse events" data-id="CD013697-fig-0009" src="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/image_n/nCD013697-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/image_t/tCD013697-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: Oral antibiotics versus placebo, Outcome 7: Adverse events</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/references#CD013697-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/media/CDSR/CD013697/image_n/nCD013697-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD013697-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Oral antibiotics compared with placebo for chronic blepharitis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Oral antibiotics compared with placebo for chronic blepharitis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adult participants with chronic blepharitis </p> <p><b>Settings:</b> tertiary care, university hospital, or private practice </p> <p><b>Intervention:</b> oral antibiotics </p> <p><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="table-header separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="table-header separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Placebo</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Oral antibiotics</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="8" valign="top"> <p><b>Subjective improvement in symptoms at 1 month and 3 months</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>OSDI, ranging from 0 to 100 (higher score indicates worse condition)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>70</p> <p>(1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="8" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low<sup>1,2,3</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean  OSDI score decreased 8.70 at 3 months.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean decrease in OSDI score at 3 months was on average <b>3.55 smaller</b> (95% CI −4.61 to 11.71). </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Bulbar conjunctival hyperemia, ranging from 0 (clear) to 4 (severe)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>70</p> <p>(1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean  bulbar conjunctival hyperemia decreased 0.60 at 3 months.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean decrease in bulbar conjunctival hyperemia at 3 months was on average <b>0.01 greater</b> (95% CI −0.38 to 0.36). </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Number of symptoms (higher score indicates worse condition)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>93 each analysis</p> <p>(1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of symptoms at 1 month was 2.01.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of symptoms at 1 month was on average <b>0.56 fewer</b> (95% CI −0.95 to −0.17) in the high‐dose group and <b>0.48 fewer</b> (95% CI −0.86 to −0.10) in the low‐dose group. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Proportion of participants with improvement</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 6.13</b> (95% CI 2.61 to 14.42) high dose vs placebo, <b>RR 6.54</b> (95% CI 2.79 to 15.30) low dose vs placebo </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>93 each analysis</p> <p>(1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>106 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>652 per 1000 (95% CI 507 to 773) in the high‐dose group and 696 per 1000 (95% CI 552 to 809) in the low‐dose group </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Measurements of eradication or decrease in numbers of colonies of positive cultures of bacteria</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No data were available for this outcome.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Clinical signs—Schirmer test scores at 1 month (mm/5 min)</b>  </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Range: 0 to 20, higher scores indicate better conditions<br/>  </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>93 each analysis</p> <p>(1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low<sup>1,2</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean Schirmer test scores in the placebo group were 15.89.</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean Schirmer test scores in the intervention group were on average <b>4.09 greater</b> (95% CI 2.38 to 5.80) in the high‐dose group and <b>3.76 greater</b> (95% CI 1.85 to 5.67) in the low‐dose group. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Clinical signs—TBUT at 1 month (seconds)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Range: 0 to 10, longer is better<br/>  </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>93 each analysis</p> <p>(1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low<sup>1,2</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean TBUT in the placebo group was 7.84</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean TBUT in the intervention group was on average <b>1.58 greater</b> (95% CI 0.57 to 2.59) in the high‐dose group and <b>1.70 greater</b> (95% CI 0.96 to 2.44) in the low‐dose group. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse events</b> </p> <p><b>at 1 month</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Cardinal side effects</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 6.13</b> (95% CI 1.94 to 19.41) high dose vs placebo, <b>RR 2.72</b> (95% CI 0.77 to 9.64) low dose vs placebo </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>93 each analysis</p> <p>(1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low<sup>1,2</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Additional 1 study reported 1 case of migraine headache and 5 cases of headaches in the oral doxycycline group, and 1 case of non‐Hodgkin's lymphoma in the placebo group (<a href="./references#CD013697-bbs2-0001" title="NCT00560703. Treatment of patients with blepharitis and facial rosacea [Efficacy and safety of COL-101 for the treatment of blepharitis in patients with facial rosacea]. clinicaltrials.gov/ct2/show/NCT00560703 (first received 20 November 2007). ">NCT00560703</a>). </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>64 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>391 per 1000 (high‐dose group)</p> <p>174 per 1000 (low‐dose group)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life measures</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No data were available for this outcome.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Economic costs and benefits of different interventions</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No data were available for this outcome.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The <b>assumed risk</b>  is based on the estimate in the control group. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>OSDI:</b> Ocular Surface Disease Index; <b>RR:</b> risk ratio; <b>TBUT:</b> tear film break‐up time </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> </p> <p><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded one level for study limitations due to high risk of attrition or reporting bias among the included studies.<br/><sup>2</sup>Downgraded one or two levels for imprecision due to wide confidence intervals.<br/><sup>3</sup>Downgraded one level for inconsistency of results. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Oral antibiotics compared with placebo for chronic blepharitis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/full#CD013697-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013697-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Oral antibiotics versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Mean change in the Ocular Surface Disease Index at week 12 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Mean change in bulbar conjunctival hyperemia at week 12 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Mean number of symptoms at month 1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Subjective improvement in symptoms at month 1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Mean Schirmer's test score at month 1 (mm/5 min) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Tear film break‐up time at month 1 (seconds)  <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Oral antibiotics versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013697.pub2/references#CD013697-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD013697.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD013697-note-0012">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD013697-note-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD013697-note-0011">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD013697-note-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pt#CD013697-note-0007">Português</a> </li> <li class="section-language"> <a class="" href="th#CD013697-note-0008">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD013697-note-0005">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD013697-note-0006">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013697\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013697\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013697\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013697\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013697\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013697\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013697\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013697\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013697\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013697\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013697\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013697\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013697\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013697\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013697\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013697\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013697\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013697\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=jxlIh5Me&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013697.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013697.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD013697.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD013697.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013697.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740729641827"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013697.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740729641830"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013697.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ee1df2b5c9377',t:'MTc0MDcyOTY0Mi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 